Lupin's Pithampur Unit 1 receives Establishment Inspection Report
Lupin has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its
Pithampur Unit-1, India facility. The inspection for the facility was conducted by the U.S. FDA between 03 February 2020 and 11 February 2020 and concluded with two observations.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Apr 30 2020 | 9:14 AM IST